Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule

NCT06206135 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia

Interventions

DRUG: the low-dose group (1.5 g/day) or the standard-dose group (4 g/day)

Sponsor

Kyowa Kirin Korea Co., Ltd.